{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:05:21Z","timestamp":1790856321776,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:00:00Z","timestamp":1638576000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science & Technology Department of Sichuan Province Project","award":["2017JY0326"],"award-info":[{"award-number":["2017JY0326"]}]},{"name":"The Subject Construction Program of Chengdu Military General Specialty Center of Spine Surgery","award":["4241232D"],"award-info":[{"award-number":["4241232D"]}]},{"name":"The Innovation Talent Training Program of General Hospital of Western Theater Command","award":["2016KC11"],"award-info":[{"award-number":["2016KC11"]}]},{"name":"The Medical and Engineering Union Program of General Hospital of Western Theater Command","award":["2016YGLH06"],"award-info":[{"award-number":["2016YGLH06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bone metastasis of colorectal cancer (CRC) often indicates a poor prognosis. Osteolysis can be observed in metastatic sites, implying an aberrant activation of osteoclasts. However, how osteoclastogenesis is regulated in metastatic microenvironment caused by colorectal cancer is still unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, mice bone metastatic model of CRC was established through injection of MC-38 or CT-26 cells. BrdU assays showed primary CD115 (\u2009+) osteoclast precursors (OCPs) proliferated at the first 2\u00a0weeks. Transcriptomic profiling was performed to identify differentially expressing genes and pathways in OCPs indirectly co-cultured with CRC cells<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expression of IL4R\u03b1 was found to be significantly upregulated in OCPs stimulated by tumor conditioned medium (CM). Further investigation indicated that IL-4 signaling regulated proliferation of OPCs through interacting with type I IL4 receptor, and neutrophils were the main source of IL-4 in bone marrow. The proliferation of OCPs can be inhibited in IL4 deficiency mice. In addition, ERK pathway was activated by IL4\/IL4R signaling. Ravoxertinib, an ERK antagonists, could significantly prevent bone destruction through inhibiting the proliferation of OCPs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study indicates the essential role of IL4\/IL4R signaling for the proliferation of OCPs in early metastasis of CRC predominantly through activating ERK pathway, which remarkedly impacts the number of osteoclasts in later stage and leads to osteolytic lesions. Moreover, Ravoxertinib could be a new therapeutical target for bone metastasis of CRC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-021-00411-2","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T10:02:29Z","timestamp":1638612149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["IL4\/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors"],"prefix":"10.1186","volume":"27","author":[{"given":"Qian","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Hong-hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Ben-jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Li-ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Li-juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8493-6046","authenticated-orcid":false,"given":"Zheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,4]]},"reference":[{"key":"411_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185736","volume":"12","author":"K Aukes","year":"2017","unstructured":"Aukes K, Forsman C, Brady NJ, et al. Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions. PLoS ONE. 2017;12: e0185736. https:\/\/doi.org\/10.1371\/journal.pone.0185736.","journal-title":"PLoS ONE"},{"key":"411_CR2","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1128\/iai.70.4.2215-2219.2002","volume":"70","author":"P Balmer","year":"2002","unstructured":"Balmer P, Devaney E. NK T cells are a source of early interleukin-4 following infection with third-stage larvae of the filarial nematode Brugia pahangi. Infect Immun. 2002;70:2215\u20139. https:\/\/doi.org\/10.1128\/iai.70.4.2215-2219.2002.","journal-title":"Infect Immun"},{"key":"411_CR3","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1073\/pnas.041493198","volume":"98","author":"AC Bendixen","year":"2001","unstructured":"Bendixen AC, Shevde NK, Dienger KM, et al. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc Natl Acad Sci U S A. 2001;98:2443\u20138. https:\/\/doi.org\/10.1073\/pnas.041493198.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"411_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0303-7207(96)03843-9","volume":"121","author":"Y Blais","year":"1996","unstructured":"Blais Y, Gingras S, Haagensen DE, et al. Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Mol Cell Endocrinol. 1996;121:11\u20138. https:\/\/doi.org\/10.1016\/0303-7207(96)03843-9.","journal-title":"Mol Cell Endocrinol"},{"key":"411_CR5","doi-asserted-by":"publisher","DOI":"10.3791\/4260","author":"JP Campbell","year":"2012","unstructured":"Campbell JP, Merkel AR, Masood-Campbell SK, et al. Models of bone metastasis. J vis Exp. 2012. https:\/\/doi.org\/10.3791\/4260.","journal-title":"J vis Exp"},{"key":"411_CR6","doi-asserted-by":"publisher","first-page":"22109","DOI":"10.1016\/S0021-9258(18)45677-3","volume":"265","author":"E Chaikin","year":"1990","unstructured":"Chaikin E, Ziltener HJ, Razin E. Protein kinase C plays an inhibitory role in interleukin 3- and interleukin 4-mediated mast cell proliferation. J Biol Chem. 1990;265:22109\u201316.","journal-title":"J Biol Chem"},{"key":"411_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/jor.1100160606","volume":"16","author":"DR Clohisy","year":"1998","unstructured":"Clohisy DR, Ramnaraine ML. Osteoclasts are required for bone tumors to grow and destroy bone. J Orthop Res. 1998;16:660\u20136. https:\/\/doi.org\/10.1002\/jor.1100160606.","journal-title":"J Orthop Res"},{"key":"411_CR8","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00262-020-02527-6","volume":"69","author":"DL Costanzo-Garvey","year":"2020","unstructured":"Costanzo-Garvey DL, Keeley T, Case AJ, et al. Neutrophils are mediators of metastatic prostate cancer progression in bone. Cancer Immunol Immunother. 2020;69:1113\u201330. https:\/\/doi.org\/10.1007\/s00262-020-02527-6.","journal-title":"Cancer Immunol Immunother"},{"key":"411_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jneuroim.2008.03.003","volume":"196","author":"AG da Silva","year":"2008","unstructured":"da Silva AG, Campello-Costa P, Linden R, et al. Interleukin-4 blocks proliferation of retinal progenitor cells and increases rod photoreceptor differentiation through distinct signaling pathways. J Neuroimmunol. 2008;196:82\u201393. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.03.003.","journal-title":"J Neuroimmunol"},{"key":"411_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/bonekey.2012.82","volume":"1","author":"L D'Amico","year":"2012","unstructured":"D\u2019Amico L, Roato I. Cross-talk between T cells and osteoclasts in bone resorption. Bonekey Rep. 2012;1:82. https:\/\/doi.org\/10.1038\/bonekey.2012.82.","journal-title":"Bonekey Rep"},{"key":"411_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022328","volume":"6","author":"S de Keijzer","year":"2011","unstructured":"de Keijzer S, Meddens MB, Kilic D, et al. Interleukin-4 alters early phagosome phenotype by modulating class I PI3K dependent lipid remodeling and protein recruitment. PLoS ONE. 2011;6: e22328. https:\/\/doi.org\/10.1371\/journal.pone.0022328.","journal-title":"PLoS ONE"},{"key":"411_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/jbmr.3364","volume":"33","author":"C Dou","year":"2018","unstructured":"Dou C, Ding N, Zhao C, et al. Estrogen deficiency-mediated M2 macrophage osteoclastogenesis contributes to M1\/M2 ratio alteration in ovariectomized osteoporotic mice. J Bone Miner Res. 2018;33:899\u2013908. https:\/\/doi.org\/10.1002\/jbmr.3364.","journal-title":"J Bone Miner Res"},{"key":"411_CR13","first-page":"337","volume":"143","author":"ML Estes","year":"1993","unstructured":"Estes ML, Iwasaki K, Jacobs BS, et al. Interleukin-4 down-regulates adult human astrocyte DNA synthesis and proliferation. Am J Pathol. 1993;143:337\u201341.","journal-title":"Am J Pathol"},{"key":"411_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1515\/BC.2001.041","volume":"382","author":"K Friedrich","year":"2001","unstructured":"Friedrich K, Wietek S. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation. Biol Chem. 2001;382:343\u201351. https:\/\/doi.org\/10.1515\/BC.2001.041.","journal-title":"Biol Chem"},{"key":"411_CR15","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1006\/bbrc.2000.2569","volume":"270","author":"M Grano","year":"2000","unstructured":"Grano M, Mori G, Minielli V, et al. Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts. Biochem Biophys Res Commun. 2000;270:1097\u2013100. https:\/\/doi.org\/10.1006\/bbrc.2000.2569.","journal-title":"Biochem Biophys Res Commun"},{"key":"411_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191455","volume":"13","author":"AR Hayes","year":"2018","unstructured":"Hayes AR, Brungs D, Pavlakis N. Osteoclast inhibitors to prevent bone metastases in men with high-risk, non-metastatic prostate cancer: a systematic review and meta-analysis. PLoS ONE. 2018;13: e0191455. https:\/\/doi.org\/10.1371\/journal.pone.0191455.","journal-title":"PLoS ONE"},{"key":"411_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cell.2013.02.053","volume":"153","author":"JE Heredia","year":"2013","unstructured":"Heredia JE, Mukundan L, Chen FM, et al. Type 2 innate signals stimulate fibro\/adipogenic progenitors to facilitate muscle regeneration. Cell. 2013;153:376\u201388. https:\/\/doi.org\/10.1016\/j.cell.2013.02.053.","journal-title":"Cell"},{"key":"411_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/1097-4636(200108)56:2<177::aid-jbm1082>3.0.co;2-h","volume":"56","author":"Y Hirashima","year":"2001","unstructured":"Hirashima Y, Ishiguro N, Kondo S, et al. Osteoclast induction from bone marrow cells is due to pro-inflammatory mediators from macrophages exposed to polyethylene particles: a possible mechanism of osteolysis in failed THA. J Biomed Mater Res. 2001;56:177\u201383. https:\/\/doi.org\/10.1002\/1097-4636(200108)56:2%3c177::aid-jbm1082%3e3.0.co;2-h.","journal-title":"J Biomed Mater Res"},{"key":"411_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2133.1994.tb08522.x","volume":"131","author":"L Horsmanheimo","year":"1994","unstructured":"Horsmanheimo L, Harvima IT, Jarvikallio A, et al. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol. 1994;131:348\u201353. https:\/\/doi.org\/10.1111\/j.1365-2133.1994.tb08522.x.","journal-title":"Br J Dermatol"},{"key":"411_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/odi.12189","volume":"20","author":"Y Hu","year":"2014","unstructured":"Hu Y, Ek-Rylander B, Wendel M, et al. Reciprocal effects of Interferon-gamma and IL-4 on differentiation to osteoclast-like cells by RANKL or LPS. Oral Dis. 2014;20:682\u201392. https:\/\/doi.org\/10.1111\/odi.12189.","journal-title":"Oral Dis"},{"key":"411_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cyto.2003.09.008","volume":"25","author":"K Hua","year":"2004","unstructured":"Hua K, Deng J, Harp JB. Interleukin-4 inhibits platelet-derived growth factor-induced preadipocyte proliferation. Cytokine. 2004;25:61\u20137. https:\/\/doi.org\/10.1016\/j.cyto.2003.09.008.","journal-title":"Cytokine"},{"key":"411_CR22","doi-asserted-by":"publisher","first-page":"112132","DOI":"10.18632\/oncotarget.22792","volume":"8","author":"J Jablonska","year":"2017","unstructured":"Jablonska J, Lang S, Sionov RV, et al. The regulation of pre-metastatic niche formation by neutrophils. Oncotarget. 2017;8:112132\u201344. https:\/\/doi.org\/10.18632\/oncotarget.22792.","journal-title":"Oncotarget"},{"key":"411_CR23","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.7150\/thno.29617","volume":"9","author":"P Jiang","year":"2019","unstructured":"Jiang P, Gao W, Ma T, et al. CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes\/macrophages. Theranostics. 2019;9:2950\u201366. https:\/\/doi.org\/10.7150\/thno.29617.","journal-title":"Theranostics"},{"key":"411_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/DCR.0000000000001071","volume":"61","author":"H Kawamura","year":"2018","unstructured":"Kawamura H, Yamaguchi T, Yano Y, et al. Characteristics and prognostic factors of bone metastasis in patients with colorectal cancer. Dis Colon Rectum. 2018;61:673\u20138. https:\/\/doi.org\/10.1097\/DCR.0000000000001071.","journal-title":"Dis Colon Rectum"},{"key":"411_CR25","doi-asserted-by":"publisher","first-page":"11389","DOI":"10.1038\/srep11389","volume":"5","author":"S Khabbazi","year":"2015","unstructured":"Khabbazi S, Goumon Y, Parat MO. Morphine modulates interleukin-4- or breast cancer cell-induced pro-metastatic activation of macrophages. Sci Rep. 2015;5:11389. https:\/\/doi.org\/10.1038\/srep11389.","journal-title":"Sci Rep"},{"key":"411_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-019-04308-8","author":"S Lei","year":"2019","unstructured":"Lei S, Ge Y, Tian S, et al. Colorectal cancer metastases to brain or bone and the relationship to primary tumor location: a population-based study. J Gastrointest Surg. 2019. https:\/\/doi.org\/10.1007\/s11605-019-04308-8.","journal-title":"J Gastrointest Surg"},{"key":"411_CR27","doi-asserted-by":"publisher","first-page":"38113","DOI":"10.18632\/oncotarget.17494","volume":"8","author":"H Liu","year":"2017","unstructured":"Liu H, Antony S, Roy K, et al. Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells. Oncotarget. 2017;8:38113\u201335. https:\/\/doi.org\/10.18632\/oncotarget.17494.","journal-title":"Oncotarget"},{"key":"411_CR28","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/eji.1830200903","volume":"20","author":"L Llorente","year":"1990","unstructured":"Llorente L, Mitjavila F, Crevon MC, et al. Dual effects of interleukin 4 on antigen-activated human B cells: induction of proliferation and inhibition of interleukin 2-dependent differentiation. Eur J Immunol. 1990;20:1887\u201392. https:\/\/doi.org\/10.1002\/eji.1830200903.","journal-title":"Eur J Immunol"},{"key":"411_CR29","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1074\/jbc.270.16.9630","volume":"270","author":"MG Malabarba","year":"1995","unstructured":"Malabarba MG, Kirken RA, Rui H, et al. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha. J Biol Chem. 1995;270:9630\u20137. https:\/\/doi.org\/10.1074\/jbc.270.16.9630.","journal-title":"J Biol Chem"},{"key":"411_CR30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4049\/jimmunol.175.2.917","volume":"175","author":"LS Mangashetti","year":"2005","unstructured":"Mangashetti LS, Khapli SM, Wani MR. IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling. J Immunol. 2005;175:917\u201325. https:\/\/doi.org\/10.4049\/jimmunol.175.2.917.","journal-title":"J Immunol"},{"key":"411_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2407-13-16","volume":"13","author":"EM McCoy","year":"2013","unstructured":"McCoy EM, Hong H, Pruitt HC, et al. IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells. BMC Cancer. 2013;13:16. https:\/\/doi.org\/10.1186\/1471-2407-13-16.","journal-title":"BMC Cancer"},{"key":"411_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/0090-1229(88)90119-5","volume":"49","author":"JG Monroe","year":"1988","unstructured":"Monroe JG, Haldar S, Prystowsky MB, et al. Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation. Clin Immunol Immunopathol. 1988;49:292\u20138. https:\/\/doi.org\/10.1016\/0090-1229(88)90119-5.","journal-title":"Clin Immunol Immunopathol"},{"key":"411_CR33","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1182\/blood-2002-11-3437","volume":"102","author":"JL Moreno","year":"2003","unstructured":"Moreno JL, Kaczmarek M, Keegan AD, et al. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood. 2003;102:1078\u201386. https:\/\/doi.org\/10.1182\/blood-2002-11-3437.","journal-title":"Blood"},{"key":"411_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2353\/ajpath.2008.071044","volume":"173","author":"Z OuYang","year":"2008","unstructured":"OuYang Z, Hirota Y, Osuga Y, et al. Interleukin-4 stimulates proliferation of endometriotic stromal cells. Am J Pathol. 2008;173:463\u20139. https:\/\/doi.org\/10.2353\/ajpath.2008.071044.","journal-title":"Am J Pathol"},{"key":"411_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12964-020-00667-x","volume":"19","author":"J Qian","year":"2021","unstructured":"Qian J, Gong ZC, Zhang YN, et al. Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer. Cell Commun Signal. 2021;19:9. https:\/\/doi.org\/10.1186\/s12964-020-00667-x.","journal-title":"Cell Commun Signal"},{"key":"411_CR36","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1084\/jem.20180661","volume":"216","author":"D Ren","year":"2019","unstructured":"Ren D, Dai Y, Yang Q, et al. Wnt5a induces and maintains prostate cancer cells dormancy in bone. J Exp Med. 2019;216:428\u201349. https:\/\/doi.org\/10.1084\/jem.20180661.","journal-title":"J Exp Med"},{"key":"411_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/0973-1482.181177","volume":"13","author":"MC Suresh Babu","year":"2017","unstructured":"Suresh Babu MC, Garg S, Lakshmaiah KC, et al. Colorectal cancer presenting as bone metastasis. J Cancer Res Ther. 2017;13:80\u20133. https:\/\/doi.org\/10.4103\/0973-1482.181177.","journal-title":"J Cancer Res Ther"},{"key":"411_CR38","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrg1122","volume":"4","author":"SL Teitelbaum","year":"2003","unstructured":"Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003;4:638\u201349. https:\/\/doi.org\/10.1038\/nrg1122.","journal-title":"Nat Rev Genet"},{"key":"411_CR39","doi-asserted-by":"publisher","unstructured":"Zi-Chen G, Jin Q, Yi-Na Z, et al. Colorectal cancer cells promote osteoclastogenesis and bone destruction through regulating EGF\/ERK\/CCL3 pathway. 2020. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20201175.","DOI":"10.1042\/BSR20201175"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00411-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-021-00411-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00411-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T10:14:57Z","timestamp":1638612897000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-021-00411-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["411"],"URL":"https:\/\/doi.org\/10.1186\/s10020-021-00411-2","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval to conduct the study was obtained from The Institutional Animal Care and Use Committee at General hospital of Western Theater Command.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. The authors declare that this manuscript has not been submitted or is not simultaneously being submitted elsewhere, and that no portion of the data has been or will be published in proceedings or transactions of meetings or symposium volumes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}